Samsung Gets European Approval for Enbrel Copy

Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news